Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Stock Information for Surgalign Holdings Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Surgalign Holdings Inc.

Surgalign Receives NASDAQ Delisting Notice Following its Chapter 11 Filing
Surgalign Enters Into Definitive Agreement to Sell Global Hardware and Biologics Business Through a Structured Sale Process Under Chapter 11 of the U.S. Bankruptcy Code
Surgalign to Participate at ISASS 2023 - 23rd Annual Conference Sponsored by the International Society for the Advancement of Spine Surgery and Medical Education Resources
Surgalign Announces First Quarter 2023 Results and Provides Update on its Business Operations
Surgalign Announces Release of HOLO(TM) AI Insights for Neurovascular Research
Surgalign Schedules First Quarter 2023 Earnings Release for May 11, 2023
Surgalign To Collaborate with Dr. Alexander Vaccaro and Dr. Pierce Nunley to Advance HOLO(TM) AI Insights and its Artificial Intelligence Technologies
Surgalign Announces Receipt of Nasdaq Deficiency Notice and Intends to Submit Plan to Regain Compliance

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.